Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs

被引：0
|
作者：
Fabrizia Veronesi
Angela Di Cesare
Gabriele Braun
Lisa Günther
Giulia Morganti
Fabrizio Rueca
Gabriele Petry
Roland Schaper
Donato Traversa
机构：
[1] University of Perugia,Veterinary Teaching Hospital
[2] University of Teramo,Faculty of Veterinary Medicine
[3] Klifovet AG,undefined
[4] Bayer Animal Health GmbH,undefined
来源：
Parasitology Research | 2017年 / 116卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 74
页数：9
相关论文
共 45 条
  • [31] Laboratory Evaluation of the Efficacy of 10 % Imidacloprid+2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs
    Bowman, Dwight D.
    Charles, Samuel D.
    Arther, Robert G.
    Settje, Terry
    PARASITOLOGY RESEARCH, 2015, 114 : S165 - S173
  • [32] Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: Results of a European field study
    Krieger K.
    Heine J.
    Dumont P.
    Hellmann K.
    Parasitology Research, 2005, 97 (Suppl 1) : S81 - S88
  • [33] A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs
    Veronesi, Fabrizia
    Morganti, Giulia
    Di Cesare, Angela
    Schaper, Roland
    Traversa, Donato
    VETERINARY PARASITOLOGY, 2014, 200 (1-2) : 133 - 138
  • [34] Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin /10 % imidacloprid (Advocate®, Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens
    Hellmann K.
    Heine J.
    Braun G.
    Paran-Dobesova R.
    Svobodova V.
    Parasitology Research, 2011, 109 (Suppl 1) : S77 - S86
  • [35] The Efficacy of a Topically Applied Imidacloprid 10 % / Moxidectin 2.5 % Formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi Worms in Experimentally Infected Dogs
    Clinton M Austin
    Dawie J Kok
    Dionne Crafford
    Roland Schaper
    Parasitology Research, 2013, 112 : 91 - 108
  • [36] The Efficacy of a Topically Applied Imidacloprid 10%/Moxidectin 2.5% Formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi Worms in Experimentally Infected Dogs
    Austin, Clinton M.
    Kok, Dawie J.
    Crafford, Dionne
    Schaper, Roland
    PARASITOLOGY RESEARCH, 2013, 112 (01) : 91 - 108
  • [37] Treatment of Naturally Notoedres cati-infested Cats with a Combination of Imidacloprid 10 % / Moxidectin 1 % Spot-on (AdvocateA® / AdvantageA® Multi, Bayer)
    Hellmann, Klaus
    Petry, Gabriele
    Capari, Balazs
    Cvejic, Dejan
    Kraemer, Friederike
    PARASITOLOGY RESEARCH, 2013, 112 (01) : 57 - 66
  • [38] Efficacy of a spot on combination containing imidacloprid 10% and moxidectin 1% (Advocate®/Advantage® Multi, Bayer Animal Health) against Ancylostoma ceylanicum in cats
    Taweethavonsawat, Piyanan
    Chungpivat, Sudchit
    Watanapongchati, Supoj
    Traub, Rebecca J.
    Schaper, Roland
    VETERINARY PARASITOLOGY, 2012, 190 (1-2) : 289 - 293
  • [39] Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats
    Donato Traversa
    Katharina Raue
    Hannah Ringeisen
    Katrin Blazejak
    Katrin Bisterfeld
    Angela Di Cesare
    Mariasole Colombo
    Claudia Böhm
    Christina Strube
    Matthias Pollmeier
    Parasites & Vectors, 15
  • [40] Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs
    McCall, John W.
    Arther, Robert
    Davis, Wendell
    Settje, Terry
    VETERINARY PARASITOLOGY, 2014, 206 (1-2) : 86 - 92
12345